| scholarly article | Q13442814 |
| P50 | author | Michael Aschner | Q64778814 |
| Marta Sidoryk-Wegrzynowicz | Q84916455 | ||
| Aaron B. Bowman | Q37830327 | ||
| P2093 | author name string | Eunsook Lee | |
| Michal Wegrzynowicz | |||
| P2860 | cites work | Albumin dialysis improves hepatic encephalopathy and decreases circulating phenolic aromatic amino acids in patients with alcoholic hepatitis and severe liver failure | Q21195009 |
| Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides | Q22242269 | ||
| GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons | Q24336322 | ||
| Structure, expression, and functional analysis of a Na(+)-dependent glutamate/aspartate transporter from rat brain | Q24563212 | ||
| Increased expression of cholesterol 24S-hydroxylase results in disruption of glial glutamate transporter EAAT2 association with lipid rafts: a potential role in Alzheimer's disease | Q24620476 | ||
| Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease | Q27860795 | ||
| Differential expression of two glial glutamate transporters in the rat brain: quantitative and immunocytochemical observations | Q28236376 | ||
| The antioxidant responsive element. Activation by oxidative stress and identification of the DNA consensus sequence required for functional activity | Q28296400 | ||
| Calcium signals induced by amyloid beta peptide and their consequences in neurons and astrocytes in culture | Q28297639 | ||
| Improvement by acetylcysteine of hemodynamics and oxygen transport in fulminant hepatic failure | Q28333321 | ||
| Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate | Q29620128 | ||
| Connexin43 null mutation increases infarct size after stroke | Q47197115 | ||
| Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-beta peptides | Q47349499 | ||
| Elevated glial brain-derived neurotrophic factor in Parkinson's diseased nigra | Q47397177 | ||
| Ammonia-induced brain edema and intracranial hypertension in rats after portacaval anastomosis | Q48109618 | ||
| beta-Amyloid immunoreactivity in astrocytes in Alzheimer's disease brain biopsies: an electron microscope study | Q48135645 | ||
| A central role for astrocytes in the inflammatory response to beta-amyloid; chemokines, cytokines and reactive oxygen species are produced | Q48179910 | ||
| Electron microscopic evaluation of brain edema in rabbits with galactosamine-induced fulminant hepatic failure: ultrastructure and integrity of the blood-brain barrier | Q48185999 | ||
| Glial cells protect neurons against oxidative stress via transcriptional up-regulation of the glutathione synthesis | Q48198259 | ||
| Amino acid changes in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy | Q48217141 | ||
| Vitamin E, ascorbate, glutathione, glutathione disulfide, and enzymes of glutathione metabolism in cultures of chick astrocytes and neurons: evidence that astrocytes play an important role in antioxidative processes in the brain | Q48226349 | ||
| Gap-junction-mediated propagation and amplification of cell injury | Q48241480 | ||
| Biochemical pathophysiology of Parkinson's disease. | Q48258284 | ||
| Mild hypothermia modifies ammonia-induced brain edema in rats after portacaval anastomosis | Q48277005 | ||
| A light and electron microscopic study of experimental portal-systemic (ammonia) encephalopathy. Progression and reversal of the disorder | Q48289526 | ||
| Synthesis of the antioxidant glutathione in neurons: supply by astrocytes of CysGly as precursor for neuronal glutathione | Q48310763 | ||
| Concomitant astroglial atrophy and astrogliosis in a triple transgenic animal model of Alzheimer's disease | Q48315992 | ||
| Effect of reducing brain glutamine synthesis on metabolic symptoms of hepatic encephalopathy | Q48324424 | ||
| The two catalytic components of the 2-oxoglutarate dehydrogenase complex in rat cerebral synaptic and nonsynaptic mitochondria: comparison of the response to in vitro treatment with ammonia, hyperammonemia, and hepatic encephalopathy. | Q48334464 | ||
| Astrocytes regulate microglial phagocytosis of senile plaque cores of Alzheimer's disease | Q48512773 | ||
| Surface complexity of human neocortical astrocytic cells: changes with development, aging, and dementia. | Q48544261 | ||
| Superoxide production and antioxidant enzymes in ammonia intoxication in rats. | Q48546082 | ||
| Aspartate aminotransferase, malate dehydrogenase, and pyruvate carboxylase activities in rat cerebral synaptic and nonsynaptic mitochondria: effects of in vitro treatment with ammonia, hyperammonemia and hepatic encephalopathy | Q48614843 | ||
| Reduction of infarct volume by halothane: effect on cerebral blood flow or perifocal spreading depression-like depolarizations | Q48644783 | ||
| Pyruvate carboxylase activity in primary cultures of astrocytes and neurons | Q48719469 | ||
| Proton magnetic resonance spectroscopy of the brain in symptomatic and asymptomatic patients with liver cirrhosis | Q48721805 | ||
| The brain in experimental portal-systemic encephalopathy. I. Morphological changes in three animal models | Q48763591 | ||
| The two patterns of reactive astrocytosis in postischemic rat brain | Q48868797 | ||
| Is glia disfunction the initial cause of neuronal death in ischemic penumbra? | Q48900856 | ||
| Glutamine, myo-inositol, and organic brain osmolytes after portocaval anastomosis in the rat: implications for ammonia-induced brain edema | Q48910533 | ||
| Ammonia stimulates glutamine uptake to the cerebral non-synaptic mitochondria of the rat. | Q48960563 | ||
| Effects of acute hyperammonemia in vivo on oxidative metabolism in nonsynaptic rat brain mitochondria | Q49066266 | ||
| EFFECT OF AN INHIBITOR OF GLUTAMINE SYNTHESIS (METHIONINE SULFOXIMINE) ON AMMONIA TOXICITY AND METABOLISM | Q51270971 | ||
| Amino acid and protein metabolism of the brain. IV. The metabolism of glutamic acid. | Q51316651 | ||
| Platelet-derived growth factor from astrocytes drives the clock that times oligodendrocyte development in culture. | Q52251326 | ||
| Calcium tsunamis: do astrocytes transmit cell death messages via gap junctions during ischemia? | Q57130117 | ||
| Regulation of Astrocyte Energy Metabolism by Neurotransmitters | Q61774085 | ||
| The absence of reactive astrocytosis is indicative of a unique inflammatory process in Parkinson's disease | Q64797268 | ||
| The role of methanethiol in the pathogenesis of hepatic encephalopathy | Q68206276 | ||
| Evaluation of the importance of transamination versus deamination in astrocytic metabolism of [U-13C]glutamate | Q71453709 | ||
| Astrocyte swelling in liver failure: role of glutamine and benzodiazepines | Q71659109 | ||
| Brain edema and intracranial hypertension in rats after total hepatectomy | Q72114703 | ||
| Immunocytochemical examination of neural rat and mouse primary cultures using monoclonal antibodies raised against pyruvate carboxylase | Q72169632 | ||
| Toxins in Hepatic Encephalopathy: The Role of the Synergistic Effect of Ammonia, Mercaptans and Short Chain Fatty Acids | Q72407940 | ||
| Maintenance of neuronal glutathione by glial cells | Q72576519 | ||
| Brain ATP depletion induced by acute ammonia intoxication in rats is mediated by activation of the NMDA receptor and Na+,K(+)-ATPase | Q72815764 | ||
| Inhibition of endotoxin-induced nitric oxide synthase production in microglial cells by the presence of astroglial cells: a role for transforming growth factor beta | Q73139232 | ||
| Astrocytes provide cysteine to neurons by releasing glutathione | Q73593740 | ||
| Inhibition of glutamine transport into mitochondria protects astrocytes from ammonia toxicity | Q79935364 | ||
| Effect of glutamine synthesis inhibition with methionine sulfoximine on the nitric oxide-cyclic GMP pathway in the rat striatum treated acutely with ammonia: a microdialysis study | Q80861407 | ||
| Metabolism of [U-13C]glutamine and [U-13C]glutamate in isolated rat brain mitochondria suggests functional phosphate-activated glutaminase activity in matrix | Q80975523 | ||
| IL-6 and IL-18 in blood may discriminate cirrhotic patients with and without minimal hepatic encephalopathy | Q81477765 | ||
| Functional changes of brain mitochondria during experimental hepatic encephalopathy | Q93529618 | ||
| Parkinson's disease. First of two parts | Q29620416 | ||
| Brain mitochondrial dysfunction and oxidative damage in Parkinson's disease. | Q30382570 | ||
| Astrocytic expression of Parkinson's disease-related A53T alpha-synuclein causes neurodegeneration in mice. | Q30494594 | ||
| Selective increase of brain lactate synthesis in experimental acute liver failure: results of a [H-C] nuclear magnetic resonance study | Q30763284 | ||
| Pathophysiology of hepatic encephalopathy: a new look at ammonia | Q30771700 | ||
| Ammonia induces the mitochondrial permeability transition in primary cultures of rat astrocytes | Q30779802 | ||
| Selective alterations of brain osmolytes in acute liver failure: protective effect of mild hypothermia | Q30891141 | ||
| Striatal manganese accumulation induces changes in dopamine metabolism in the cirrhotic rat. | Q31873342 | ||
| Glial cell participation in the degeneration of dopaminergic neurons in Parkinson's disease | Q33689541 | ||
| Brain edema in acute liver failure: inhibition by L-histidine | Q33703761 | ||
| The glial scar and central nervous system repair | Q33731601 | ||
| Metabolism and functions of glutathione in brain. | Q33908238 | ||
| Amyloid-beta aggregates cause alterations of astrocytic metabolic phenotype: impact on neuronal viability | Q34021511 | ||
| Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. | Q34116455 | ||
| The role of astrocytes in hepatic encephalopathy | Q34173518 | ||
| MANF: a new mesencephalic, astrocyte-derived neurotrophic factor with selectivity for dopaminergic neurons | Q34204195 | ||
| 3-hydroxymorphinan is neurotrophic to dopaminergic neurons and is also neuroprotective against LPS-induced neurotoxicity. | Q34376043 | ||
| Ischaemic brain oedema | Q34581444 | ||
| Activity-dependent regulation of energy metabolism by astrocytes: an update | Q34656867 | ||
| Astrocyte targeted overexpression of Hsp72 or SOD2 reduces neuronal vulnerability to forebrain ischemia. | Q35026095 | ||
| Gap junctions and connexin expression in the normal and pathological central nervous system. | Q35059232 | ||
| Astrocytes and brain injury | Q35061615 | ||
| Astrocytes and stroke: networking for survival? | Q35074272 | ||
| Glutathione pathways in the brain. | Q35129250 | ||
| Synthesis and release of neuroactive substances by glial cells | Q35254472 | ||
| The neurophysiology of glial cells | Q35319978 | ||
| Neuroenergetics: calling upon astrocytes to satisfy hungry neurons | Q35677227 | ||
| Toxicity of amyloid beta peptide: tales of calcium, mitochondria, and oxidative stress | Q35707277 | ||
| The pathophysiologic basis of hepatic encephalopathy: central role for ammonia and inflammation | Q36255793 | ||
| Glutamine: a Trojan horse in ammonia neurotoxicity | Q36606140 | ||
| Review of the final report of the 1998 Working Party on definition, nomenclature and diagnosis of hepatic encephalopathy | Q36734114 | ||
| Aromatic amino acid metabolism during liver failure | Q36826844 | ||
| Neuronal cell death in hepatic encephalopathy | Q36939309 | ||
| Nrf2-mediated neuroprotection in the MPTP mouse model of Parkinson's disease: Critical role for the astrocyte | Q37115302 | ||
| Reassessing the amyloid cascade hypothesis of Alzheimer's disease | Q37187966 | ||
| Connexin and pannexin hemichannels of neurons and astrocytes. | Q37292232 | ||
| Astroglia in dementia and Alzheimer's disease. | Q37341695 | ||
| Functions of mature mammalian astrocytes: a current view | Q37710857 | ||
| Role of glial cells in the regulation of the brain ion microenvironment | Q38208816 | ||
| Some features of the nigrostriatal dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse | Q38677190 | ||
| Increased apoptosis and inflammation after focal brain ischemia in mice lacking connexin43 in astrocytes | Q38736872 | ||
| Plasma and Brain Amino Acids in Fulminant Hepatic Failure and their Relationship to Hepatic Encephalopathy | Q39117120 | ||
| Glutamine Synthetase: Glial Localization in Brain | Q39138188 | ||
| The metabolic fate of 13N-labeled ammonia in rat brain | Q39252649 | ||
| Transport and Metabolism of Glutamate and Gaba in Neurons and Glial Cells | Q40085062 | ||
| Valproate protects dopaminergic neurons in midbrain neuron/glia cultures by stimulating the release of neurotrophic factors from astrocytes. | Q40232814 | ||
| Role of glutathione in determining the differential sensitivity between the cortical and cerebellar regions towards mercury-induced oxidative stress | Q40260107 | ||
| Upregulation of protease-activated receptor-1 in astrocytes in Parkinson disease: astrocyte-mediated neuroprotection through increased levels of glutathione peroxidase | Q40330344 | ||
| Effect of acute ammonia intoxication on cerebral metabolism in rats with portacaval shunts | Q40529811 | ||
| Cellular processing of beta-amyloid precursor protein and the genesis of amyloid beta-peptide | Q40790952 | ||
| Proton spectroscopy of brain glutamine in acute liver failure | Q40980897 | ||
| Free radical scavenging systems of rat astroglial cells in primary culture: effects of anoxia and drug treatment | Q41097322 | ||
| Inhibition of brain glutamine accumulation prevents cerebral edema in hyperammonemic rats | Q41134959 | ||
| Microglia cells are the driving force in fibrillar plaque formation, whereas astrocytes are a leading factor in plague degradation | Q41478344 | ||
| Pyruvate carboxylase: an astrocyte-specific enzyme implicated in the replenishment of amino acid neurotransmitter pools | Q41485422 | ||
| High affinity glutamate transporters: regulation of expression and activity. | Q41532645 | ||
| Cellular distribution and kinetic properties of high-affinity glutamate transporters | Q41724740 | ||
| Phosphate-activated glutaminase activity is enhanced in brain, intestine and kidneys of rats following portacaval anastomosis | Q41820650 | ||
| A simulation study of brain compartments. Metabolism of glutamate and related substances in mouse brain | Q41872028 | ||
| Mechanism of action and value of N-acetylcysteine in the treatment of early and late acetaminophen poisoning: a critical review | Q42540215 | ||
| Role of aquaporin-4 in the development of brain oedema in liver failure | Q43069745 | ||
| Manganese elevations in blood of children with congenital portosystemic shunts | Q43585436 | ||
| The uptake of cysteine in cultured primary astrocytes and neurons | Q43625050 | ||
| Ammonia-induced production of free radicals in primary cultures of rat astrocytes | Q43760354 | ||
| Differences in neurotransmitter synthesis and intermediary metabolism between glutamatergic and GABAergic neurons during 4 hours of middle cerebral artery occlusion in the rat: the role of astrocytes in neuronal survival | Q43820426 | ||
| Cytochemical identification of cerebral glycogen and glucose-6-phosphatase activity under normal and experimental conditions. II. Choroid plexus and ependymal epithelia, endothelia and pericytes | Q44218625 | ||
| Astrocytes accumulate Aβ42 and give rise to astrocytic amyloid plaques in Alzheimer disease brains | Q44410484 | ||
| Taurine reduces ammonia- and N-methyl-D-aspartate-induced accumulation of cyclic GMP and hydroxyl radicals in microdialysates of the rat striatum. | Q44428823 | ||
| Suppression of ammonia-induced astrocyte swelling by cyclosporin A. | Q44675685 | ||
| Involvement of brain lactate in neuronal metabolism | Q44696182 | ||
| Effects of methionine sulfoximine on the glutamine and glutamate content and cell volume in rat cerebral cortical slices: involvement of mechanisms not related to inhibition of glutamine synthesis. | Q44798753 | ||
| Glutamine-induced free radical production in cultured astrocytes | Q44817562 | ||
| Low myo-inositol and high glutamine levels in brain are associated with neuropsychological deterioration after induced hyperammonemia. | Q44886424 | ||
| Ex vivo analysis of lactate and glucose metabolism in the rat brain under different states of depressed activity | Q45054284 | ||
| Astroglial plasticity and glutamate function in a chronic mouse model of Parkinson's disease | Q45097883 | ||
| Ex vivo NMR study of lactate metabolism in rat brain under various depressed states | Q45159486 | ||
| Amyloid-beta peptide decreases glutamate uptake in cultured astrocytes: involvement of oxidative stress and mitogen-activated protein kinase cascades | Q45768606 | ||
| Minocycline attenuates oxidative/nitrosative stress and cerebral complications of acute liver failure in rats. | Q45970550 | ||
| Nrf2, a multi-organ protector? | Q46572845 | ||
| Defective tumor necrosis factor-alpha-dependent control of astrocyte glutamate release in a transgenic mouse model of Alzheimer disease | Q46778008 | ||
| Adult mouse astrocytes degrade amyloid-beta in vitro and in situ | Q46779933 | ||
| Depletion of brain glutathione by buthionine sulfoximine enhances cerebral ischemic injury in rats | Q46830452 | ||
| Glutamine in the mechanism of ammonia-induced astrocyte swelling | Q46975455 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | astrocyte | Q502961 |
| P304 | page(s) | 115-123 | |
| P577 | publication date | 2010-11-12 | |
| P1433 | published in | Toxicologic Pathology | Q7830407 |
| P1476 | title | Role of astrocytes in brain function and disease | |
| P478 | volume | 39 |
| Q35864788 | A Peephole into the Brain: Neuropathological Features of Alzheimer's Disease Revealed by in vivo Two-Photon Imaging |
| Q38965286 | A Slice of the Suicidal Brain: What Have Postmortem Molecular Studies Taught Us? |
| Q64888205 | APOE4 Causes Widespread Molecular and Cellular Alterations Associated with Alzheimer's Disease Phenotypes in Human iPSC-Derived Brain Cell Types. |
| Q46584010 | Achillolide A Protects Astrocytes against Oxidative Stress by Reducing Intracellular Reactive Oxygen Species and Interfering with Cell Signaling |
| Q99585317 | Activation of both transforming growth factor-β and bone morphogenetic protein signalling pathways upon traumatic brain injury restrains pro-inflammatory and boosts tissue reparatory responses of reactive astrocytes and microglia |
| Q48528549 | Ammonium accumulation is a primary effect of 2-methylcitrate exposure in an in vitro model for brain damage in methylmalonic aciduria |
| Q28068029 | Astrocyte Differentiation of Human Pluripotent Stem Cells: New Tools for Neurological Disorder Research |
| Q64071824 | Astrocytes Do Not Forfeit Their Neuroprotective Roles After Surviving Intense Oxidative Stress |
| Q28393397 | Astrocytes acquire resistance to iron-dependent oxidative stress upon proinflammatory activation |
| Q38422519 | Astrocytes in neurodegenerative disease |
| Q39015589 | Astrocytic JWA expression is essential to dopaminergic neuron survival in the pathogenesis of Parkinson's disease. |
| Q37626767 | Astrocytic abnormalities and global DNA methylation patterns in depression and suicide |
| Q39181656 | Astroglia as a cellular target for neuroprotection and treatment of neuro-psychiatric disorders |
| Q42427133 | Astroglial integrins in the development and regulation of neurovascular units |
| Q28391993 | Blockade of P2 nucleotide receptors after spinal cord injury reduced the gliotic response and spared tissue |
| Q41660607 | Blood-Brain Barrier Dysfunction and the Pathogenesis of Alzheimer's Disease |
| Q36110724 | Bone marrow mesenchymal stem cells transplantation promotes the release of endogenous erythropoietin after ischemic stroke |
| Q26866330 | Brain repair: cell therapy in stroke |
| Q85417338 | Cholesterol-induced astrocyte activation is associated with increased amyloid precursor protein expression and processing |
| Q44688668 | Cross-talk between neurons and astrocytes in response to bilirubin: adverse secondary impacts |
| Q38035191 | Defective autophagy in Parkinson's disease: role of oxidative stress. |
| Q37710820 | Delayed transplantation of precursor cell-derived astrocytes provides multiple benefits in a rat model of Parkinsons |
| Q28116376 | EBI2 regulates intracellular signaling and migration in human astrocyte |
| Q48103841 | Effects of cholesterol transport inhibitor U18666A on APP metabolism in rat primary astrocytes |
| Q34984390 | Effects of wind-dispelling drugs and deficiency-nourishing drugs of Houshiheisan compound prescription on astrocyte activation and inflammatory factor expression in the corpus striatum of cerebral ischemia rats |
| Q33706292 | Electroacupuncture attenuates cervical spinal cord injury following cerebral ischemia/reperfusion in stroke-prone renovascular hypertensive rats |
| Q64272672 | F-THK5351 PET Imaging in the Behavioral Variant of Frontotemporal Dementia |
| Q29248442 | FcRγ-dependent immune activation initiates astrogliosis during the asymptomatic phase of Sandhoff disease model mice |
| Q90225806 | Fumaric Acids Do Not Directly Influence Gene Expression of Neuroprotective Factors in Highly Purified Rodent Astrocytes |
| Q38197952 | Glial epigenetics in neuroinflammation and neurodegeneration |
| Q99728806 | HIV-Tat and Cocaine Impact Brain Energy Metabolism: Redox Modification and Mitochondrial Biogenesis Influence NRF Transcription-Mediated Neurodegeneration |
| Q45127728 | Hippocampal dysfunction in cured Cushing's syndrome patients, detected by (1) H-MR-spectroscopy |
| Q34152540 | Histology of the central nervous system |
| Q90406498 | Improved HCN channels in pyramidal neurons and their new expression levels in pericytes and astrocytes in the gerbil hippocampal CA1 subfield following transient ischemia |
| Q48649422 | Increased expression of hyperpolarization-activated cyclic nucleotide-gated (HCN) channels in reactive astrocytes following ischemia. |
| Q48246215 | Insula-specific H magnetic resonance spectroscopy reactions in heavy smokers under acute nicotine withdrawal and after oral nicotine substitution |
| Q33887259 | Insulin Attenuates Beta-Amyloid-Associated Insulin/Akt/EAAT Signaling Perturbations in Human Astrocytes |
| Q52151873 | Lipopolysaccharide-Induced Apoptosis of Astrocytes: Therapeutic Intervention by Minocycline. |
| Q91848620 | Long-term neuropathological and/or neurobehavioral effects of antenatal corticosteroid therapy in animal models: a systematic review |
| Q48726331 | Loss of Transient Receptor Potential Ankyrin 1 Channel Deregulates Emotion, Learning and Memory, Cognition, and Social Behavior in Mice |
| Q41654351 | Maternal inflammation leads to impaired glutamate homeostasis and up-regulation of glutamate carboxypeptidase II in activated microglia in the fetal/newborn rabbit brain |
| Q26863224 | Metals, oxidative stress and neurodegeneration: a focus on iron, manganese and mercury |
| Q38844786 | Mutant SOD1G93A triggers mitochondrial fragmentation in spinal cord motor neurons: neuroprotection by SIRT3 and PGC-1α. |
| Q38157889 | NMDA Receptors in Glial Cells: Pending Questions |
| Q27004226 | Neuroinflammation in Alzheimer's disease |
| Q36238937 | Neuron-astrocyte interactions in neurodegenerative diseases: Role of neuroinflammation |
| Q39467116 | Neuroprotection by Combined Administration with Maslinic Acid, a Natural Product from Olea europaea, and MK-801 in the Cerebral Ischemia Model. |
| Q38259550 | Neuroprotective effects of resveratrol in Alzheimer disease pathology. |
| Q28393646 | Neuroprotective effects of urate are mediated by augmenting astrocytic glutathione synthesis and release |
| Q48062902 | Oleanolic Acid Inhibiting the Differentiation of Neural Stem Cells into Astrocyte by Down-Regulating JAK/STAT Signaling Pathway |
| Q42589440 | Palmitate-activated astrocytes via serine palmitoyltransferase increase BACE1 in primary neurons by sphingomyelinases |
| Q35007247 | Phenotyping dividing cells in mouse models of neurodegenerative basal ganglia diseases |
| Q52571298 | Prostaglandin E2 Produced by Alginate-Encapsulated Mesenchymal Stromal Cells Modulates the Astrocyte Inflammatory Response. |
| Q35769973 | Respiration and substrate transport rates as well as reactive oxygen species production distinguish mitochondria from brain and liver |
| Q38974731 | Role of Astrocytes in Central Respiratory Chemoreception. |
| Q39704909 | Safety of Intravenous Methamphetamine Administration During Ibudilast Treatment |
| Q28570210 | Sex differences and effects of estrogenic compounds on the expression of inflammatory molecules by astrocytes exposed to the insecticide dimethoate |
| Q89658090 | Small Vessel Disease-Related Dementia: An Invalid Neurovascular Coupling? |
| Q38658583 | Stem cell-derived astrocytes: are they physiologically credible? |
| Q34240433 | Stem cells as therapeutic vehicles for the treatment of high-grade gliomas |
| Q42352469 | Targeting astrocytes ameliorates neurologic changes in a mouse model of Alzheimer's disease. |
| Q89509387 | The Potential Role of Astrocytes in Parkinson's Disease (PD) |
| Q89660195 | The Role of Dietary Antioxidants in the Pathogenesis of Neurodegenerative Diseases and Their Impact on Cerebral Oxidoreductive Balance |
| Q45324691 | The effects of prenatal methylmercury exposure on trace element and antioxidant levels in rats following 6-hydroxydopamine-induced neuronal insult |
| Q36348658 | The participation of insulin-like growth factor-binding protein 3 released by astrocytes in the pathology of Alzheimer's disease |
| Q54396799 | Theophylline potentiates lipopolysaccharide-induced NO production in cultured astrocytes. |
| Q44646913 | Triglyceride-rich lipoprotein lipolysis products increase blood-brain barrier transfer coefficient and induce astrocyte lipid droplets and cell stress |
| Q92140077 | [¹⁸F]THK5351 PET Imaging in Patients with Mild Cognitive Impairment |
Search more.